Hub · Peptide Quality & Verification
How mass spectrometry confirms peptide identity
Mass spectrometry confirms peptide identity by weighing the molecules (clusters of bonded atoms) of a peptide, a short chain of amino acids, the building blocks of proteins, and comparing it with the mass (molecular weight) calculated from the named sequence, the order of those amino acids. A matching mass supports the sequence without proving it, so the European Medicines Agency (EMA, the European Union's medicines regulator) recommends at least two orthogonal tests, meaning tests built on different principles (EMA/CHMP/CVMP/QWP/367182/2025).
01What it measuresContents
Your body makes peptides every day: short chains of amino acids that carry messages between your cells. Even there, weight is a blunt clue, because two different amino acids can weigh exactly the same. A mass spectrometer, the instrument that does the weighing here, reads weight with great care, and this page, part of the peptide quality & verification hub, explains how a peptide is weighed, what a match means, and where a match stops.
Two questions run through it. How does an instrument weigh something far too small to see? And how do scientists tell apart molecules that weigh the same? Two neighbouring pages help: how to read a certificate of analysis, the maker's test sheet for one production run, and what a lot number lets a researcher verify, the code that names that run.
Key facts
| Method | Mass spectrometry (MS), often joined to liquid chromatography, which sorts a dissolved mixture by how fast each part moves through a packed tube (LC-MS) |
|---|---|
| What it reports | The mass-to-charge ratio (m/z): mass divided by number of electric charges, the property that lets electric fields steer an ion, a charged molecule |
| Unit of mass | The dalton (Da): one twelfth of the mass of a carbon-12 atom, carbon-12 being the most common form of carbon (International Bureau of Weights and Measures, The International System of Units, 9th edition, 2019) |
| Identity guideline | EMA/CHMP/CVMP/QWP/367182/2025, dated 4 December 2025: at least two orthogonal methods recommended |
| Earlier guideline | ICH Q6A, dated 6 October 1999, from the International Council for Harmonisation (ICH, a body that writes shared drug-testing guidelines): a single retention time, the delay before a part leaves the tube, is not specific, since identity tests should tell closely related molecules apart; HPLC/MS, high-performance liquid chromatography joined to a mass spectrometer, is generally acceptable |
| Published worked example | Leuprolide: calculated m/z 1209.6533, measured 1209.6515 (McCarthy et al., Pharmaceutical Research, 2023) |
| Does not show on its own | Which catalogue lot a sample came from, purity (the share of the sample that is the named peptide), content (how much peptide is present), safety or permission |
What does mass spectrometry measure in a peptide?
Mass spectrometry measures the mass-to-charge ratio, written m/z, of ions made from a sample. An ion is a molecule carrying an electric charge, and the m/z is its mass divided by its number of charges. Electrospray ionization, described in a 1989 paper in Science, turns dissolved molecules into ions that can carry several charges each (Fenn et al., Science, 1989). Mass is counted in daltons (Da), each equal to a twelfth of a carbon-12 atom's mass (International Bureau of Weights and Measures, 2019). The instrument records m/z values, and names and sequences come from interpreting them.
Atoms of one element come as isotopes, forms that differ in their neutrons, the particles in the atom's core. Most carbon atoms are carbon-12 and a small share are the heavier carbon-13 (National Institute of Standards and Technology, Atomic Weights and Isotopic Compositions for Carbon). A peptide's monoisotopic mass is its mass built from the most common form of each element, and Verbeke et al. report impurity masses this way (Verbeke et al., Journal of Pharmaceutical Analysis, 2015).
How does a mass match confirm peptide identity?
A mass match confirms identity only as far as the measured mass equals the mass calculated from the named sequence. McCarthy et al. give a worked case: leuprolide, a peptide of nine amino acids, has a calculated monoisotopic protonated m/z of 1209.6533, and the measured value was 1209.6515 (McCarthy et al., Pharmaceutical Research, 2023). Protonated means the molecule picked up one hydrogen ion, which supplies the charge. Agreement within 0.002 shows a fine reading of the weight. It supports the sequence without proving it, because other molecules can weigh the same.
A mass check can also catch the wrong product. Verbeke et al. examined 15 peptides chosen for varying purity and found the main peak, the tallest signal on the chromatography chart, was the desired peptide for 14 of them (Verbeke et al., 2015). The fifteenth main peak sat 2.1 Da below the requested mass, which pointed to a disulfide bond, a sulfur-to-sulfur link between two cysteines, amino acids that carry sulfur (Verbeke et al., 2015). The 15 were not a random sample, so 14 of 15 is not a failure rate. The retatrutide molecular-formula record shows a formula and its calculated mass.
How does fragmentation show a peptide's sequence?
Fragmentation shows sequence by breaking selected peptide ions into pieces and weighing the pieces, a two-stage method called tandem mass spectrometry (MS/MS). Hunt et al. described reading amino acid sequences this way in 1986, using collision-activated dissociation, in which collisions knock the ions apart (Hunt et al., Proceedings of the National Academy of Sciences, 1986). Pieces that keep the start of the chain are called b ions, and pieces that keep its end are called y ions. Verbeke et al. saw a shift of 14 Da at b4 (first four amino acids) but not at b3 (first three), which placed a methyl group, a small carbon-and-hydrogen unit, on the fourth amino acid of one impurity (Verbeke et al., 2015).
A published case shows what complete evidence looks like. For leuprolide, MS/MS gave complete coverage of the amino acid sequence, meaning every position in the chain was accounted for (McCarthy et al., 2023). The EMA asks for representative spectra, fragment assignments and tables of calculated and observed masses (EMA/CHMP/CVMP/QWP/367182/2025). A bare statement that a mass matched is thinner evidence than that.
Can two different peptides have the same mass?
Two different peptides can have the same mass, which is why a mass match cannot stand alone. McCarthy et al. note that isobaric amino acids, meaning amino acids of identical mass, may require additional techniques, and their testing scheme uses amino acid analysis, a count of which amino acids are present, to tell leucine from isoleucine in bivalirudin, a peptide holding one of each (McCarthy et al., Pharmaceutical Research, 2023). The same paper lists chirality testing, a check for D-amino acids, the mirror-image forms of amino acids that some peptides contain.
The EMA lists molecular mass (MS or LC-MS) and amino acid sequence confirmation as separate tests, with LC-MS/MS of the intact molecule among the techniques for the second (EMA/CHMP/CVMP/QWP/367182/2025). Its list gives enantiomeric purity, the share of the correct mirror-image form, a further test using techniques that tell mirror images apart. A reading of mass alone fills only the first line.
Which identity tests do guidelines expect for peptides?
Guidelines expect more than one kind of evidence for peptide identity. The EMA's December 2025 guideline on synthetic peptides, those built by chemistry rather than by living cells, recommends at least two orthogonal methods, names mass and LC-MS among the appropriate ones, and requires that the chosen tests unambiguously confirm the sequence (EMA/CHMP/CVMP/QWP/367182/2025). ICH Q6A (1999) states that identification by a single chromatographic retention time is not regarded as specific, while HPLC/MS is generally acceptable (ICH Q6A, 1999). Two different principles give stronger evidence than one, and a measured mass is only one principle.
The EMA text names other appropriate methods: relative retention time, which compares a retention time with a reference; peptide mapping, cutting a peptide into pieces and weighing them; bioactivity, a measured biological response; amino acid analysis; and NMR, nuclear magnetic resonance, which reads how atoms behave in a magnetic field (EMA/CHMP/CVMP/QWP/367182/2025). McCarthy et al. describe reference standards, materials that tests are compared against, verified by retention time, NMR, MS and chirality testing together (McCarthy et al., 2023).
Evidence limits
What has research not shown about mass spectrometry and peptide identity?
Published evidence does not show that mass spectrometry alone proves peptide identity, and none of the sources read for this page tested a catalogue lot. Verbeke et al. studied 98 synthetic quorum-sensing peptides, signalling molecules that bacteria use, and examined the main peak of only 15 (Verbeke et al., 2015). McCarthy et al. describe six reference standards, not commercial lots (McCarthy et al., 2023). ICH Q6A may apply to synthetic peptides of low molecular weight in marketing applications for new medicines (ICH Q6A, 1999).
This page explains methods. It does not test or certify any catalogue lot, and a spectrum describes only the sample that was measured, so the lot number on the label and the report is what ties the two together. A mass spectrum also says nothing about permission to supply or use a material, and research-use-only material is not a medicine and is not for human or animal use. For the paperwork around identity, see what research grade actually means.
Comparison
A reading checklist: what a mass spectrometry result can show for each identity question, and which separate test answers what it leaves open. A general sketch, not a report from any real lot.
| Question | What mass spectrometry can show | What needs a separate test |
|---|---|---|
| Does the measured mass equal the calculated mass? | Whether the measured m/z agrees with the m/z calculated from the named sequence | Whether a different molecule of the same mass is the one measured |
| Is the order of amino acids right? | Fragment ions placed along the chain, up to complete coverage of the sequence | A second, orthogonal identity method |
| Is it leucine or isoleucine? | Nothing alone: the two amino acids weigh the same | Amino acid analysis |
| Is any amino acid the mirror-image D form? | Nothing from mass alone: mirror-image forms weigh the same | Chirality testing |
| Is the main chromatography peak the named peptide? | LC-MS weighs what leaves the tube at each time, so a wrong main peak can be caught | A second method built on a different principle |
| How pure is it, and how much is there? | Which masses are present, with impurities assigned by fragmentation | Chromatographic purity and content tests |
| Which catalogue lot does a spectrum describe? | Nothing: a spectrum describes the sample that was measured | The lot number matched between label and report |
FAQ
What does MS/MS mean in peptide testing?
MS/MS means tandem mass spectrometry: the first stage weighs the intact ions, one ion type is selected and broken, and the second stage weighs the pieces. Verbeke et al. called the two stages MS1 and MS2 and used the second to assign structures to 73% of 84 impurities (Verbeke et al., 2015).
Is a matching mass enough to show a peptide is what its name says?
A matching mass is necessary but not sufficient. The EMA recommends at least two orthogonal identity methods and asks for tests that leave no doubt about the sequence (EMA, December 2025). Amino acids of identical mass are one reason: McCarthy et al. needed a separate test for leucine and isoleucine (McCarthy et al., 2023).
Does mass spectrometry measure peptide purity?
Mass spectrometry names what is present, while the two studies cited here took purity from chromatography. Verbeke et al. measured purity from peak areas and used mass spectrometry to identify the main peak and impurities, and McCarthy et al. list purity and strength, the amount of peptide, as chromatography tests (Verbeke et al., 2015; McCarthy et al., 2023).
Part of
Peptide Quality & VerificationHow research peptide material is tested, what a certificate of analysis actually records, and how a buyer checks that a vial matches its paperwork. Every article in this hub is about verification, not about use.
Citations
4 sourcesVerbeke F et al. Journal of Pharmaceutical Analysis. 2015;5(3):169-181.
doi:10.1016/j.jpha.2014.12.002McCarthy D et al. Pharmaceutical Research. 2023;40(6):1317-1328.
doi:10.1007/s11095-023-03493-1Fenn JB et al. Science. 1989;246(4926):64-71.
doi:10.1126/science.2675315Hunt DF et al. Proceedings of the National Academy of Sciences. 1986;83(17):6233-6237.
doi:10.1073/pnas.83.17.6233
Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.